Cytokinetics
CYTK
$65.34
Share price
0.83%
Change (1 day)
74.71%
Change (1 year)
Categories
Cytokinetics (CYTK) - Net assets
Net assets on the balance sheet as of December 2023 : -$0.39 B
According to Cytokinetics
's latest financial reports the company has -$0.39 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Cytokinetics - Net assets on balance sheet (from 2003 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $-0.39 B | 258.04% |
| 2022-12-31 | $-0.11 B | -144.25% |
| 2021-12-31 | $0.24 B | 115.08% |
| 2020-12-31 | $0.11 B | -1136.69% |
| 2019-12-31 | $-10.94 M | -142.17% |
| 2018-12-31 | $25.93 M | -76.39% |
| 2017-12-31 | $0.10 B | 16.41% |
| 2016-12-31 | $94.36 M | 37.57% |
| 2015-12-31 | $68.59 M | -25.5% |
| 2014-12-31 | $92.06 M | 69.1% |
| 2013-12-31 | $54.44 M | -22.32% |
| 2012-12-31 | $70.08 M | 45.47% |
| 2011-12-31 | $48.17 M | -31.68% |
| 2010-12-31 | $70.51 M | -30.48% |
| 2009-12-31 | $0.10 B | 103.81% |
| 2008-12-31 | $49.76 M | -50.19% |
| 2007-12-31 | $99.91 M | -6.02% |
| 2006-12-31 | $0.10 B | 44.52% |
| 2005-12-31 | $73.56 M | -31.61% |
| 2004-12-31 | $0.10 B | -216.87% |
| 2003-12-31 | $-92.04 M | 51.9% |
| 2002-12-31 | $-60.59 M | 62.21% |
| 2001-12-31 | $-37.36 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $6.23 B | -1,713.16% | 🇺🇸 USA |
 Trevena TRVN | $3.54 M | -100.92% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $0.70 B | -281.43% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | -$0.16 B | -59.11% | 🇺🇸 USA |
 Array Technologies ARRY | $0.61 B | -258.03% | 🇺🇸 USA |